Goldman Sachs
TWST icon

Goldman Sachs’s Twist Bioscience TWST Stock Holding History

Goldman Sachs’s Portfolio TWST Stock Details TWST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$145M Sell
1,408,418
-297,128
-17% -$19.3M 0.01% 954
2026
Q1 		$81M Buy
1,705,546
+8,952
+0.5% +$401K 0.01% 1192
2025
Q4 		$53.8M Buy
1,696,594
+69,574
+4% +$2.17M 0.01% 1450
2025
Q3 		$45.8M Buy
1,627,020
+101,977
+7% +$3.09M 0.01% 1487
2025
Q2 		$56.1M Buy
1,525,043
+592,065
+63% +$20.5M 0.01% 1259
2025
Q1 		$36.6M Buy
932,978
+37,577
+4% +$1.69M 0.01% 1463
2024
Q4 		$41.6M Sell
895,401
-26,017
-3% -$1.18M 0.01% 1461
2024
Q3 		$41.6M Buy
921,418
+76,460
+9% +$3.64M 0.01% 1391
2024
Q2 		$41.6M Buy
844,958
+366,095
+76% +$14.9M 0.01% 1294
2024
Q1 		$16.4M Sell
478,863
-254,683
-35% -$9.19M ﹤0.01% 2011
2023
Q4 		$27M Sell
733,546
-179,405
-20% -$4.15M 0.01% 1635
2023
Q3 		$18.5M Buy
912,951
+232,416
+34% +$5.11M ﹤0.01% 1874
2023
Q2 		$13.9M Buy
680,535
+79,005
+13% +$1.18M ﹤0.01% 2152
2023
Q1 		$9.07M Buy
601,530
+119,129
+25% +$2.63M ﹤0.01% 2508
2022
Q4 		$11.5M Sell
482,401
-204,897
-30% -$5.94M ﹤0.01% 2451
2022
Q3 		$24.2M Buy
687,298
+282,480
+70% +$12M 0.01% 1700
2022
Q2 		$14.2M Sell
404,818
-360,059
-47% -$12.8M ﹤0.01% 2186
2022
Q1 		$37.8M Sell
764,877
-36,164
-5% -$2M 0.01% 1530
2021
Q4 		$62M Buy
801,041
+109,156
+16% +$11.2M 0.01% 1166
2021
Q3 		$74M Buy
691,885
+31,172
+5% +$3.57M 0.02% 952
2021
Q2 		$88M Buy
660,713
+89,270
+16% +$10.4M 0.02% 814
2021
Q1 		$70.8M Sell
571,443
-75,022
-12% -$11.4M 0.02% 893
2020
Q4 		$91.3M Buy
646,465
+208,803
+48% +$23.2M 0.02% 680
2020
Q3 		$33.3M Buy
437,662
+205,942
+89% +$12.8M 0.01% 1326
2020
Q2 		$10.5M Buy
231,720
+173,950
+301% +$6.24M ﹤0.01% 2231
2020
Q1 		$1.77M Buy
57,770
+13,455
+30% +$362K ﹤0.01% 3388
2019
Q4 		$931K Sell
44,315
-11,895
-21% -$278K ﹤0.01% 4170
2019
Q3 		$1.34M Buy
56,210
+20,615
+58% +$599K ﹤0.01% 3823
2019
Q2 		$1.03M Buy
+35,595
New +$942K ﹤0.01% 3979

Other funds holding TWST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Goldman Sachs's TWST Position: Q2 2026 in Review

Goldman Sachs reduced its Twist Bioscience (TWST) stake by 17% in Q2 2026, selling an estimated $19.3M and leaving 1,408,418 shares worth $145M. The position accounts for 0.01% of the portfolio, ranked #954.

Goldman Sachs first reported a position in TWST in Q2 2019 and has held it in 29 quarters since. 338 funds tracked by Wall St. Rank hold TWST as of Q2 2026.

  • Goldman Sachs held 1,408,418 shares of Twist Bioscience worth $145M as of Q2 2026.
  • Goldman Sachs sold 297,128 Twist Bioscience shares in Q2 2026, an estimated $19.3M.
  • Twist Bioscience made up 0.01% of Goldman Sachs's portfolio in Q2 2026, its #954 holding.
  • Goldman Sachs first reported a position in Twist Bioscience in Q2 2019 and has held it in 29 quarters since.
  • 338 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2026.

Based on Goldman Sachs's 13F filing for Q2 2026, filed 14 Aug 2026.